AR048010A1 - Nuevas 5-acilindolinonas conteniendo cicloalquilo, su preparacion y uso como medicamento - Google Patents
Nuevas 5-acilindolinonas conteniendo cicloalquilo, su preparacion y uso como medicamentoInfo
- Publication number
- AR048010A1 AR048010A1 ARP050100967A ARP050100967A AR048010A1 AR 048010 A1 AR048010 A1 AR 048010A1 AR P050100967 A ARP050100967 A AR P050100967A AR P050100967 A ARP050100967 A AR P050100967A AR 048010 A1 AR048010 A1 AR 048010A1
- Authority
- AR
- Argentina
- Prior art keywords
- cyclloqual
- acilindolinones
- preparation
- new
- medicinal product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Abstract
La presente se refiere a 5-acilindolinonas con contenido en cicloalquilo de la formula general (1), en la que R1 a R3 están definidos como en las reivindicaciones 1 a 6, sus tautomeros, sus enantiomeros, sus diastereoisomeros, sus mezclas y sus sales, los cuales presentan valiosas propiedades farmacologicas, en especial un efecto inhibidor sobre proteína quinasas, en particular un efecto inhibidor sobre la actividad de la glucogeno-sintasa-quinasa (GSK-3).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004012070A DE102004012070A1 (de) | 2004-03-12 | 2004-03-12 | Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
AR048010A1 true AR048010A1 (es) | 2006-03-15 |
Family
ID=34895265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050100967A AR048010A1 (es) | 2004-03-12 | 2005-03-11 | Nuevas 5-acilindolinonas conteniendo cicloalquilo, su preparacion y uso como medicamento |
Country Status (12)
Country | Link |
---|---|
US (1) | US7262206B2 (es) |
EP (1) | EP1727812B1 (es) |
JP (1) | JP2007528884A (es) |
AR (1) | AR048010A1 (es) |
AT (1) | ATE419244T1 (es) |
CA (1) | CA2559143A1 (es) |
DE (2) | DE102004012070A1 (es) |
ES (1) | ES2320564T3 (es) |
PE (1) | PE20060103A1 (es) |
TW (1) | TW200604169A (es) |
UY (1) | UY28795A1 (es) |
WO (1) | WO2005087761A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200630337A (en) * | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
WO2007110449A1 (en) * | 2006-03-29 | 2007-10-04 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use |
US8791264B2 (en) * | 2006-04-13 | 2014-07-29 | Purdue Pharma L.P. | Benzenesulfonamide compounds and their use as blockers of calcium channels |
US8937181B2 (en) * | 2006-04-13 | 2015-01-20 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
US8399486B2 (en) * | 2007-04-09 | 2013-03-19 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use thereof |
US8765736B2 (en) * | 2007-09-28 | 2014-07-01 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
US20110046395A1 (en) * | 2008-01-25 | 2011-02-24 | Boehringer Ingelheim International Gmbh | Process for the manufacture of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative |
EP2338888A1 (en) | 2009-12-24 | 2011-06-29 | Almirall, S.A. | Imidazopyridine derivatives as JAK inhibitors |
WO2018160967A1 (en) | 2017-03-02 | 2018-09-07 | Board Of Regents, The University Of Texas System | Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
GB9716557D0 (en) * | 1997-08-06 | 1997-10-08 | Glaxo Group Ltd | Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity |
DE19816624A1 (de) * | 1998-04-15 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
DE19824922A1 (de) * | 1998-06-04 | 1999-12-09 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
JP2002523455A (ja) * | 1998-08-31 | 2002-07-30 | スージェン・インコーポレーテッド | 蛋白質キナーゼ活性の調節剤としての幾何学的に制限された2−インドリノン誘導体 |
ES2209527T3 (es) * | 1998-12-17 | 2004-06-16 | F. Hoffmann-La Roche Ag | "44- y 5-alquiniloxindolels y 4- y 5-alqueniloxindones. |
DE19949209A1 (de) * | 1999-10-13 | 2001-04-19 | Boehringer Ingelheim Pharma | In 5-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
DE102004012069A1 (de) * | 2004-03-12 | 2005-09-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue aryl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel |
-
2004
- 2004-03-12 DE DE102004012070A patent/DE102004012070A1/de not_active Withdrawn
-
2005
- 2005-03-05 AT AT05715812T patent/ATE419244T1/de not_active IP Right Cessation
- 2005-03-05 WO PCT/EP2005/002407 patent/WO2005087761A1/de not_active Application Discontinuation
- 2005-03-05 JP JP2007502262A patent/JP2007528884A/ja active Pending
- 2005-03-05 DE DE502005006380T patent/DE502005006380D1/de not_active Expired - Fee Related
- 2005-03-05 CA CA002559143A patent/CA2559143A1/en not_active Abandoned
- 2005-03-05 ES ES05715812T patent/ES2320564T3/es active Active
- 2005-03-05 EP EP05715812A patent/EP1727812B1/de not_active Not-in-force
- 2005-03-10 PE PE2005000279A patent/PE20060103A1/es not_active Application Discontinuation
- 2005-03-10 UY UY28795A patent/UY28795A1/es not_active Application Discontinuation
- 2005-03-10 US US11/077,355 patent/US7262206B2/en active Active
- 2005-03-11 TW TW094107405A patent/TW200604169A/zh unknown
- 2005-03-11 AR ARP050100967A patent/AR048010A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
ES2320564T3 (es) | 2009-05-25 |
TW200604169A (en) | 2006-02-01 |
DE502005006380D1 (de) | 2009-02-12 |
DE102004012070A1 (de) | 2005-09-29 |
PE20060103A1 (es) | 2006-03-20 |
EP1727812B1 (de) | 2008-12-31 |
CA2559143A1 (en) | 2005-09-22 |
UY28795A1 (es) | 2005-10-31 |
US20050203104A1 (en) | 2005-09-15 |
ATE419244T1 (de) | 2009-01-15 |
EP1727812A1 (de) | 2006-12-06 |
JP2007528884A (ja) | 2007-10-18 |
US7262206B2 (en) | 2007-08-28 |
WO2005087761A1 (de) | 2005-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR048009A1 (es) | Nuevas 5-acilindolinonas conteniendo alquilo, su preparacion y uso como medicamentos | |
AR048010A1 (es) | Nuevas 5-acilindolinonas conteniendo cicloalquilo, su preparacion y uso como medicamento | |
AR047917A1 (es) | Derivados de 4-benzimidazol-2-il-piridazin-3-ona, preparacion de los mismos, y su empleo en medicamentos | |
UY28749A1 (es) | "8-(3-amino-piperidin-1il)-xantinas, su preparación y su uso como medicamento | |
ECSP078058A (es) | Nuevas glicinamidas sustituidas, su preparación y su uso como medicamentos | |
UY27181A1 (es) | Derivados de xantina, su preparación y su empleo como medicamentos. | |
UY28103A1 (es) | Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos | |
GT200400206A (es) | Pirimidinas sustituidas con sulfoximina como inhibidores de cdk y/o vegf, su preparacion y sus usos como medicamento. | |
ECSP055617A (es) | 8-[3-amino-piperidin-1-il]-xantinas, su preparación y su utilización como medicamentos | |
UY30979A1 (es) | Pirrolidinamidas sustituidas, su preparacion y su uso como medicamentos | |
UY29826A1 (es) | Derivados de pirimidina, sales farmaceuticamente aceptables, esteres de los mismos hidrolisables in vivo, procesos de preparacion y aplicaciones | |
UY29072A1 (es) | Aminas policíclicas sustituidas con arilo, procedimientos para su preparación y su uso como medicamentos | |
DOP2009000257A (es) | Inhibidores de cinasa p70 s6 | |
UY29853A1 (es) | Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas- | |
ECSP088345A (es) | Nuevas pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina | |
ATE508747T1 (de) | C-kit kinase-hemmer | |
EA201070395A1 (ru) | Ингибиторы polo-подобных киназ | |
ECSP088824A (es) | Prolinamidas sustituidas, su preparación y su uso como medicamentos | |
ECSP088774A (es) | Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricación. | |
ECSP10010561A (es) | Pirimidin-5-carboxamidas sustituidas 281 | |
DOP2006000226A (es) | Derivados de carbamoilbenzotriazol como inhibidores de lipasas fosfolipasas | |
UY32463A (es) | Derivados de (1-{[5-(4-halo-2-trifluorometil-fenilamino)piridin-2-ilmetil]-carbamoil -ciclopropil)-amidas de ácidos pirimidin-carboxílicos y similares; sus enantiómeros, sus diastereoisómeros, y sus sales, fisiológicamente tolerables. | |
UY30087A1 (es) | Piperazinas y piperidinas como potenciadoras de mglur5 | |
TW200607805A (en) | Novel pyridazinone derivatives, methods for producing them and their use as pharmaceuticals | |
AR056860A1 (es) | Derivados de triazol inhibidores de receptores de quinasa tgf-beta1, composiciones farmaceuticas que los contienen y usos para el tratamiento de tumores |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |